Setmelanotide
RM-493-040-A
Phase 3 small_molecule active
Quick answer
Setmelanotide for Hypothalamic Obesity is a Phase 3 program (small_molecule) at RHYTHM PHARMACEUTICALS, INC. with 3 ClinicalTrials.gov record(s).
Program details
- Company
- RHYTHM PHARMACEUTICALS, INC.
- Indication
- Hypothalamic Obesity
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active